In concert with partner Senseonics Holdings, Ascensia Diabetes Care announced that the U.S. Food and Drug Administration signed off on the Eversense E3 Continuous Glucose Monitoring System (CGM) System.

A 2017 study found that more than 700 million adults and children worldwide are obese, calling it a “rising pandemic.”

Bayer will discontinue the sale of the healthcare company’s birth control product Essure in the United States.